ANATARA LIFESCIENCES LTD

- AUD (-)

- End-of-day data - Australië Aandelen

Open:	-
Verschil:	-
Volume:	-

Laag:	-
Hoog:	-
Hoog - Laag:	-

Type:	Aandelen
Ticker:	ANR
ISIN:	AU000000ANR0

Anatara Lifesciences Limited (ANR.AX) Investor Presentation

Melbourne, Australia (ABN Newswire) - Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals, is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today to investors.

To view the Presentation, please visit:
https://abnnewswire.net/lnk/20846ZE6

About Anatara Lifesciences Limited:

Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

Source:
Anatara Lifesciences Limited

Contact:

Steven Lydeamore 
CEO, Anatara Lifesciences Ltd
+61 (0) 438 027 172
[email protected]

Eric Kuret
Market Eye
+61 (0) 417 311 335
[email protected]

ABN Newswire

ABN Newswire is a business newswire and press release distribution service for listed companies on stock exchanges globally. ABN Newswire distributes company announcements to the professional platforms, finance portals and syndicates important corporate news to a wide variety of news aggregators and financial news systems.